Biochemistry and physiology of the leukotrienes

Clinical Reviews in Allergy and Immunology

Volumn 17, Issue 1-2, 1999, Pages 27-42

  Barnes, Neil C ^a   Smith, Lewis J ^b  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; HISTAMINE; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR; METHACHOLINE; PEPTIDOLEUKOTRIENE; WATER;

ARACHIDONIC ACID METABOLISM; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHIL; HUMAN; INFLAMMATORY CELL; INFLAMMATORY DISEASE; REVIEW;

EID: 0032776032     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02737595     Document Type: Review

References (61)

1. Brocklehurst WE. Slow-reacting substance and related compounds. Prog Allergy 1962;6:539-558.
2. Murphy RC, Hammarstrom S, Samuelsson B. Leukotriene C: A slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 1979;76: 4275-4279.
3. Corey EJ, Clark DA, Goto G, Marfat A, Mioskowski C, Samuelsson B, Hammarstrom S. Stereospecific total synthesis of a "slow-reacting substance" of anaphylaxis, leukotriene C-1. J Am Chem Soc 1980;102:1436-1439.
4. Samhoun MN, Conroy DM, Piper PJ. Pharmacological profile of leukotrienes E4, N-acetyl E4 and of four of their novel omega- and beta-oxidative metabolites in airways of guinea-pig and man in vitro. Br J Pharmacol 1989;98:1406-1412.
5. Peatfield AC, Piper PJ, Richardson PS. The effect of leukotriene C4 on mucin release into the cat trachea in vivo and in vitro. Brit J Pharmcol 1982;77:391-393.
6. Holroyde MC, Altounyan RE, Cole M, Dixon M, Elliott EV. Bronchoconstriction produced in man by leukotrienes C and D. Lancet 1981;ii:17,18.
7. Weiss JW, Drazen JM, Coles N, McFadden ER, Weller PF, Corey EJ, Lewis RA, Austen KF. Bronchoconstrictor effects of leukotriene C in humans. Science 1982; 216:196-198.
8. Weiss JW, Drazen JM, McFadden ER, Weller P, Corey EJ, Lewis RA, Austen KF. Airway constriction in normal humans produced by inhalation of leukotriene D. JAMA 1983;249:2814-2817.
9. Barnes NC, Piper PJ, Costello JF. Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. Thorax 1984; 39:500-504.
10. Kem R, Smith LJ, Patterson R, Krell RD, Bernstein PR. Characterization of the airway response to inhaled leukotriene D4 in normal subjects. Am Rev Respir Dis 1986;133:1127-1132.
11. Kumlin M, Dahlen B, Bjorck T, Zefterstrom O, Granstrom E, Dahlen S-E. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4 and histamine in asthmatics. Am Rev Respir Dis 145: 1992;1087-1091.
12. Piper PJ, Samboun MN. Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea pig lung in vitro. Br J Pharm 1982;77:267-275.
13. Bisgaard H, Groth S. Bronchial effects of leukotriene D4 inhalation in normal human lung. Clin Sci 1987;72:585-592.
14. Wood-Baker R, Town IG, Benning B, Holgate ST. The reproducibility and effect on non-specific airway responsiveness of inhaled prostaglandin D2 and leukotriene D4 in asthmatic subjects. Br J Clin Pharmacol 1995;39:119-123.
15. Spector SL, Smith LJ, Glass M. Effects of six weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. Am J Respir Crit Care Med 1994;150:618-623.
16. Barnes NC, Pujet J-C. Pranlukast, a novel leukotriene receptor antagonist: The first European, placebo-controlled, multicentre clinical study in asthma. Thorax 1997;52:523-527.
17. Barnes NC, Zarzewski JT, Piper PJ, Costello JF. Reproducibility of histamine and leukotriene D4 inhalation challenge in normal humans. Brit J Clin Pharm 1985;20:554P (abstract).
18. Barnes N, Piper PJ, Costello JF. The effect of an oral leukotriene antagonist L649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man. J Allergy Clin Immunol 1987;79:816-821.
19. Evans JM, Barnes NC, Zakrzewski JT, et al. L648,051 a novel cysteinyl leukotriene antagonist is active by the inhaled route in man. Br J Clin Pharmacol 1989;28:125-135.
20. Smith LJ, Geller S, Ebright L, Glass M, Thyrum PT. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219. Am Rev Respir Dis 1990;141: 988-992.
21. Fuller RW, Black PN, Dollery CT. Effect of the oral leukotriene antagonist LYI71,883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects. J Allergy Clin Immunol 1989;83:939-944.
22. Piper PJ, Samboun MN. Comparison of the actions of leukotriene E4 with those of leukotrienes B4, C4 and D4 in guinea pig lung and ileal smooth muscle in vitro, in Samuelsson B, Paoletti R, Ramwell P (eds). Advances in Prostaglandin, Thromboxane and Leukotriene Research. Raven, New York, 1985; pp. 127-131.
23. Davidson AB, Lee TH, Scanlon PD, Solway J, McFadden ER. Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects. Am Rev Respir Dis 1987;135:333-337.
24. Barnes NC, Piper PJ. The actions of leukotrienes in human lung in vitro and in vivo, in Piper PJ (ed). The Leukotrienes: Their Biological Significance. Raven, New York, 1986; pp. 199-212.
25. Griffin M, Weiss JW, Leitch AG, McFadden ER, Corey EJ, Austen KF, Drazen JM. Effects of leukotriene D4 on the airways in asthma. New Engl J Med 1983;308:436-439.
26. Adelroth E, Morris MM, Hargreave FE, O'Byrne PM. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal subjects. N Engl J Med 1986;315:480-484.
27. Smith LJ, Greenberger PA, Patterson R, Krell RD, Bernstein PR. The effect of inhaled leukotriene D4 in humans. Am Rev Respir Dis 1985;131:368-372.
28. Bisgaard H, Groth S, Madsen F. Bronchial hyperreactivity to leukotriene D4 in exogenous asthma. Br Med J 1985;290:1468-1471.
29. Barnes NC, Piper PJ, Costello JF. Hyperresponsiveness of asthmatics to inhaled leukotriene D4. Am Rev Respir Dis 1985;131:A24 (abstract).
30. Drazen JM, Austen KF. Leukotrienes and airway responses. Am Rev Respir Dis 1987;136:985-998,.
31. Hardy CC, Robinson C, Tattersfield AK, Holgate ST. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med 1984;311:209-213.
32. Mann JS, Holgate ST, Renwick ACT, Cushley MJ. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 1986;61:1667-1676.
33. Black PN, Fuller RW, Taylor GW, Barnes PJ, Dollery CT. Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects. Thorax 1989;44:491-495.
34. Sampson SE, Costello JF, Sampson AP. The effect of inhaled leukotriene B4 in normal and in asthmatic subjects. Am J Respir Crit Care Med 1997;155:1789-1792.
35. Kaye MG, Smith LJ. Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects. Am Rev Respir Dis 1990;131:993-997.
36. Bel EH, van der Veen H, Kramps JA, Dijkman JH, Sterk PJ. Maximal airway narrowing to inhaled leukotriene D4 in normal subjects. Am Rev Respir Dis 1987;136:979-984.
37. Arm JP, Spur BW, Lee TH. The effects of inhaled leukotriene E4 on the airway hyperresponsiveness to histamine in subjects with asthma and normal subjects. J Allergy Clin Immunol 1988;82:654-660.
38. O'Hickey SP, Hawksworth RJ, Fong CY, Arm JP, Spur BW, Lee TH. Leukotrienes C4, D4 and E4 enhance histamine responsiveness in asthmatic airways. Am Rev Respir Dis 1991;144:1053-1057.
39. Bianco S, Robushci M, Vaghi A, Simone P, Folco G, Berti F, Pasargiklian M. Effects of leukotriene C4 on the bronchial response to an ultrasonic mist of water, in Herzog H, Perruchoud AP (eds). Progress in Respiratory Research: Asthma and Bronchial Hyperreactivity. Basel, S Karger AG, 1985; pp. 82-86.
40. O'Byrne PM, Leikauf GD, Aizawa H, Bethal RA, Ueki IF, Holtzman MJ, Nadel JA. Leukotriene B4 induces airway hyperresponsiveness in dogs. J Appl Physiol 1985;59:1941-1946.
41. Martin TR, Pistorese BP, Chi KY, Goodman RB, Matthay MA. Effects of leukotriene B4 in the human lung. J Clin Invest 1989;94:1609-1619.
42. Chavis C, Godard P, Michel FB, Crastes de Paulet A, Damon M. Sulfidopeptide leukotrienes contribute to human alveolar macrophage activation in asthma. Prostaglandins Leukotrienes Essential Fatty Acids 1991;42:95-100.
43. Smith LJ, Shamsuddin M, Houston M. Effect of leukotriene D4 and platelet activating factor on human alveolar macrophage eicosanoid and PAF synthesis. Am Rev Respir Dis 1993;148:682-688.
44. Smith LJ, Houston M, Anderson J, Shamsuddin M. Leukotriene D4 increases alveolar macrophage LTB4 synthesis in patents with asthma. Am Rev Respir Dis 1993;147:A311 (abstract).
45. Balter MS, Eschenbacher WL, Peters-Golden M. Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic and asthmatic subjects. Am Rev Respir Dis 1988;138:1134-1142.
46. Restrick LJ, Sampson AP, Piper PJ, Costello JF. Reduction in leukotriene B4 generation by bronchoalveolar ravage cells in asthma. Thorax 1995;50:67-73.
47. Laitinen LA, Laitinen A, Haahtela I', Vilkka V, Spur BW, Lee TH. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 1993;341:989-990.
48. Diamant Z, Hiltermann JT, van Rensen EL, et al. The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma. Am J Respir Crit Care Med 1997;155:1247-1253.
49. Martin TR, Raugi G, Merritt TL, Henderson WR. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by resident human alveolar macrophages. J Clin Invest 1987;80:1114-1124.
50. Palmer RM, Stepney RJ, Haggs GA, Eakins KE. Chemokinetic activities of arachidonic and lipoxygenase products in leukocytes of different species. Prostaglandins 1980;20:411-418.
51. Israel E, Rubin P, Kemp J, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild to moderate asthma. Ann Int Med 1993;119:1059-1066.
52. Israel E, Cohn J, Dube L, Drazen J. Effect of treatment with zileuton, a 5 lipoxygenase inhibitor, in patients with asthma. JAMA 1996;275:931-936.
53. Smith LJ, Kern R, Patterson R, Krell RD, Bernstein PR. Mechanism of leukotriene D4-induced bronchoconstriction in normal subjects. J Allergy Clin Immunol 1987;80:340-347.
54. Roberts JA, Giembycz MA, Raebum D, Rodger IW, Thomson NC. In vitro and in vivo effect of verapamil on human airway responsiveness to leukotriene D4. Thorax 1986;41:12-16.
55. Roberts JA, Rodger IW, Thomson NC. Effect of verapamil and sodium cromoglycate on leukotriene D4-induced bronchoconstriction in patients with asthma. Thorax 1986;41:753-758.
56. Albazzaz MK, Patel KR. Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma. Thorax 1988;43:306-311.
57. Smith LJ, Glass M, Minkwitz MC. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: Concentration effect study of ICI 204,219. Clin Pharmacol Ther 1993;54:430-436.
58. Kips JC, Joos GF, de Lepeleire I, et al. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human. Am Rev Respir Dis 1991; 144:617-621.
59. Spada CS, Nieves AL, Krauss A H-P, Woodward DF. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. J Leukocyte Biol 1994;55:183-191.
60. Joris I, Majno G, Corey EJ, Lewis RA. The mechanism of vascular leakage induced by leukotriene E4. Am J Pathol 1987;126:19-24.
61. Stewart AG, Thompson DC, Fennessy MR. Involvement of capsaicin-sensitive afferent neurons in a vagal-dependent interaction between leukotriene D4 and histamine on bronchomotor tone. Agents Actions 1984;15:500-508.